Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-11

Clinical Trial Update: Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating the neuroprotective effects of resveratrol in Gulf War Illness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: VISN 17 Center of Excellence | Conditions: Gulf War Illness | Phase 2 | Status: UNKNOWN